OA Flashcards
OA
- AKA Degenerative joint disease or hypertrophic arthritis
- Most common joint disease
- Affects almost 50% in those >65 y.o. and almost everyone >75 y.o. (generally from age and repetitive motion)
- Women twice as likely to develop OA, especially in knees and hands
- Characterized by pain, joint stiffness, muscle weakness
OA General Criteria
- Presence of Pain
- Bony changes on exam
- Normal erythrocyte sedimentation rate
- Characteristic radiographs
- Presence of erosion and marked proliferation in proximal and distal interphalangeal joints of hands
Hip OA Criteria
- Hip pain PLUS 2 of the following:
- ESR < 20
- Radiographic femoral or acetabular osteophytes
- Radiography joint space narrowing
Knee OA Criteria
- Knee pain and radiographic osteophytes PLUS 1 of the following:
- Age > 50 y.o.
- Morning stiffness of 30 minutes or less
- Crepitus (creaking) on motion
OA General Information
- Primarily idiopathic
- Generally asymmetrical
- Treat to relieve pain
OA Labs
- ESR < 20
- RF Titer < 1:40 (negative)
- Non-inflammatory synovial fluid
OA Pharmacological Treatment Options
DEPENDS ON AFFECTED SITE: -Tylenol -Topical NSAIDs/capsaicin pOral NSAIDs (<75 y.o.) -COX-2 selective inhibitor -Tramadol -Duloxetine -Intraarticular CS
ESR
- General marker of inflammation
- Measures how quickly RBCs settle in blood sample
- Nonspecific
- Increased fibrinogen auses RBCs to stick together and settle faster
- High ESR, more inflammation
OA Etiology
- Increased body weight strongly associated with hip, knee, and hand OA
- Activities involving repetitive motion or injury increase risk
Localized v.s. Generalized OA
Localized = 1-2 sites Generalized = 3+ sites
OA Pathophysiological Changes
- Initial thickening of articular cartilage as ECM is damagedand water content increases
- Proliferation of chondrocytes
- Decline in response of chondrocytes to stabilize or restore tissue, resulting in progressive cartilage loss
- Increased turnover of adjacent subchondral bone
- Release of vasoactive peptides and enzymes, causing cartilage degradation, neovascularization, ad increased leakiness of adjacent cartilage
As cartilage is destroyed…
- More brittle, stiffer bone with decreased weight-bearing ability
- Development of sclerosis and microfractures
- Microfractures lead to new bone formation at the joint margins called “osteophytes”
Joint Capsule and Synovium
- Inflammation from inflammatory mediators from chondrocytes
- Inflammation localized to affected joint
OA Physical Exam - Hands
- Asymmetrical involvement
- Distal interphalangeal (DIP) joints - Heberden’s nodes (osteophytes)
- Proximal interphalangeal (PIP) joints - Bouchard’s nodes
Pain of OA
- Activation of nociceptive nerce endings within the joint by mechanical and chemical irritants
- Distention of synovial capsule by increased joint fluid
Pain Assessment in Dementia
- Facial expressions
- Vocal expressions
- Rigid, tense body posture
- Fidgeting, pacing, rocking
- Changes in eating or sleeping habits
- Increased confusion, irritability, distress, or wandering
OA Nonpharm
- Rest
- Physical therapy - ROM, muscle strengthening, aerobic exercise
- Assistive devices
- Splints
- Diet-weight loss
- Thermal modalities
Hand OA Pharm Guidelines
-No strong recommendations for pharm. management
Use one or more of the following:
- Topical capsaicin
- Topical NSAIDs
- Oral NSAIDs
- Tramadol
Conditionally recommend to not use:
- Intraarticular therapies
- Opioid analgesics
Persons >75 y.o. should use:
-Topical NSAIDs over oral
Knee OA Pharm Guidelines
Use one of the following:
- Tylenol
- Oral NSAIDs
- Topical NSAIDs
- Tramadol
- Intraarticular CS injections
Do NOT Use
- Chondroitin sulfate
- Glucosamine
- Topical capsaicin
No recommendations regarding:
- Intraarticular hyaluronates
- Duloxetine
- Opioid analgesics
Hip OA Pharm Guidelines
Use one of the following:
- Tylenol
- Oral NSAIDs
- Tramadol
- Intraarticular CS injections
Do NOT use:
- Chondoitin sulfate
- Glucosamine
No recommendation for:
- Topical NSAIDs
- Intraarticular hyaluronate injections
- Duloxetine
- Opioid analgesics